The research, which analyzed the medical records of 2.5 million VA patients, suggests these medications could help with cardiovascular, kidney and liver diseases and even improve blood clotting, respiration and infection resistance.
Additionally, the study, published Jan. 20 in Nature Medicine, indicates that the drugs could reduce suicidal thoughts, challenging earlier concerns about their mental health effects.
However, the research also highlighted some potential risks, including gastrointestinal issues, reflux, headaches and pancreatitis. An unexpected link to arthritis was also observed, though researchers noted this finding warrants further investigation.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.